Does Rallies show Form 4 insider transactions for BLCO?

Yes. Rallies tracks BLCO insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is BLCO research on Rallies investment advice?

No. Rallies provides research, data, and educational context for BLCO. It does not provide personalized investment advice.

BLCO (Bausch + Lomb Corporation) Stock Analysis - Insider Trades

Bausch + Lomb Corporation (BLCO) is a publicly traded Healthcare sector company. As of May 20, 2026, BLCO trades at $16.00 with a market cap of $5.74B and a P/E ratio of -26.08. BLCO moved -0.03% today. Year to date, BLCO is -3.57%; over the trailing twelve months it is +37.87%. Its 52-week range spans $10.45 to $21.69. Analyst consensus is neutral with an average price target of $18.60. Rallies surfaces BLCO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading BLCO stock inside the company?

Recent BLCO insider activity includes Bailey A Robert D bought 14.60K, Eldessouky Sam bought 4.00K, SAUNDERS BRENT L bought 14.70K, Ross Thomas W. Sr. bought 4.50K, and Alfonso Eduardo bought 4.30K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

BLCO Key Metrics

Key financial metrics for BLCO
Metric	Value
Price	$16.00
Market Cap	$5.74B
P/E Ratio	-26.08
EPS	$-0.62
Dividend Yield	0.00%
52-Week High	$21.69
52-Week Low	$10.45
Volume	310.31K
Avg Volume	0
Revenue (TTM)	$5.21B
Net Income	$-211.00M
Gross Margin	0.00%

Recent BLCO Insider Trades

Bailey A Robert D bought 14.60K (~$250.33K) on Mar 6, 2026.
Eldessouky Sam bought 4.00K (~$68.52K) on Mar 6, 2026.
SAUNDERS BRENT L bought 14.70K (~$251.96K) on Mar 6, 2026.
Ross Thomas W. Sr. bought 4.50K (~$79.56K) on Mar 3, 2026.
Alfonso Eduardo bought 4.30K (~$76.97K) on Mar 2, 2026.

Latest BLCO News

Bausch + Lomb jumps after Q1 sales growth and raised 2026 guidance — Apr 30, 2026
Bausch Health Q1 Revenue Up 12% to $2.524B While Net Debt Drops $100M — Apr 30, 2026
Bausch + Lomb Targets Net Zero by 2050 with 10% Power Cut and 50% Lighter Lens Packaging — Apr 22, 2026
Bausch + Lomb falls 3% as investors brace for April 29 earnings — Apr 21, 2026
Bausch + Lomb rises as market prices in 2026 guidance ahead of April earnings — Apr 8, 2026

BLCO Analyst Consensus

12 analysts cover BLCO: 0 strong buy, 4 buy, 7 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $18.60.

Common questions about BLCO

Who is trading BLCO stock inside the company?: Recent BLCO insider activity includes Bailey A Robert D bought 14.60K, Eldessouky Sam bought 4.00K, SAUNDERS BRENT L bought 14.70K, Ross Thomas W. Sr. bought 4.50K, and Alfonso Eduardo bought 4.30K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for BLCO?: Yes. Rallies tracks BLCO insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is BLCO research on Rallies investment advice?: No. Rallies provides research, data, and educational context for BLCO. It does not provide personalized investment advice.